Cambiar Investors LLC Lowers Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Cambiar Investors LLC lowered its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 87.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 23,780 shares of the company's stock after selling 164,965 shares during the quarter. Cambiar Investors LLC's holdings in HealthEquity were worth $2,282,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the business. Raymond James Trust N.A. boosted its holdings in HealthEquity by 4.8% during the 3rd quarter. Raymond James Trust N.A. now owns 2,905 shares of the company's stock valued at $238,000 after acquiring an additional 132 shares during the period. UMB Bank n.a. boosted its holdings in HealthEquity by 65.6% during the 4th quarter. UMB Bank n.a. now owns 414 shares of the company's stock valued at $40,000 after acquiring an additional 164 shares during the period. Truist Financial Corp boosted its holdings in HealthEquity by 7.0% during the 2nd quarter. Truist Financial Corp now owns 2,864 shares of the company's stock valued at $247,000 after acquiring an additional 188 shares during the period. Elk River Wealth Management LLC lifted its holdings in shares of HealthEquity by 0.3% in the 3rd quarter. Elk River Wealth Management LLC now owns 66,181 shares of the company's stock worth $5,417,000 after buying an additional 217 shares during the period. Finally, Nicolet Advisory Services LLC lifted its holdings in shares of HealthEquity by 5.8% in the 3rd quarter. Nicolet Advisory Services LLC now owns 4,218 shares of the company's stock worth $330,000 after buying an additional 233 shares during the period. Hedge funds and other institutional investors own 99.55% of the company's stock.

HealthEquity Stock Down 1.1 %

NASDAQ:HQY traded down $1.25 during mid-day trading on Friday, hitting $112.69. 483,217 shares of the company's stock traded hands, compared to its average volume of 757,794. The company has a fifty day moving average of $102.14 and a 200 day moving average of $90.76. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $115.59. The company has a market capitalization of $9.77 billion, a P/E ratio of 103.39, a P/E/G ratio of 1.61 and a beta of 0.55. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period last year, the business earned $0.40 EPS. On average, analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current year.

Wall Street Analyst Weigh In

HQY has been the subject of several research reports. Mizuho initiated coverage on HealthEquity in a report on Wednesday, December 4th. They issued an "outperform" rating and a $126.00 target price for the company. JMP Securities upped their target price on HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a report on Tuesday, December 10th. BTIG Research upped their target price on HealthEquity from $110.00 to $130.00 and gave the stock a "buy" rating in a report on Thursday, November 14th. Bank of America upped their target price on HealthEquity from $100.00 to $120.00 and gave the stock a "buy" rating in a report on Wednesday, November 13th. Finally, Barrington Research upped their target price on HealthEquity from $105.00 to $120.00 and gave the stock an "outperform" rating in a report on Monday, December 2nd. One equities research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company's stock. Based on data from MarketBeat, HealthEquity has a consensus rating of "Moderate Buy" and an average price target of $110.71.

Insider Activity at HealthEquity

In other news, Director Stuart B. Parker sold 25,000 shares of the stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the transaction, the director now directly owns 19,061 shares of the company's stock, valued at approximately $1,843,579.92. This represents a 56.74 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $101.56, for a total value of $837,870.00. Following the completion of the transaction, the director now directly owns 66,469 shares in the company, valued at $6,750,591.64. This represents a 11.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 39,000 shares of company stock valued at $3,895,788 in the last ninety days. Corporate insiders own 2.20% of the company's stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.